WBZ News Radio 1030 Boston Scientific Feels Regulatory Blunder Recoil Forbes Shares of Boston Scientific nosedived on Monday after the company announced that it has stopped shipment of two of its medical devices after determining that manufacturing process changes have not yet been approved by the Food and Drug Administration. ..
Continue reading about Boston Scientific Feels Regulatory Blunder Recoil – Forbes